Karch’s Focus on Nursing
Pharmacology
9th Edition
Author(s)Rebecca G. Tucker
TEST BANK
Question 1
Clinical Scenario
A nurse is participating in a research seminar about the
development of a new antihypertensive medication. The
presenter explains that the drug has shown promising results in
laboratory studies and animal testing and is now being
prepared for testing in healthy human volunteers.
,Question
Which stage of drug development is the medication entering?
Options
A. Preclinical testing
B. Phase I clinical trial
C. Phase III clinical trial
D. Phase IV surveillance
Correct Answer
B. Phase I clinical trial
Rationale
Phase I clinical trials are the first studies involving human
participants, typically healthy volunteers. These trials focus
primarily on determining safety, dosage ranges,
pharmacokinetics, and identifying common adverse effects.
Why the Other Options Are Incorrect
A. Preclinical testing occurs before any human subjects are
enrolled and involves laboratory and animal studies.
C. Phase III trials involve large groups of patients with the target
condition to evaluate effectiveness and monitor adverse
reactions.
D. Phase IV surveillance occurs only after the medication
receives regulatory approval and is marketed.
,Learning Objective
Differentiate the phases of drug development and identify the
purpose of each phase.
Bloom's Taxonomy
Apply
Difficulty
Easy
NCLEX Client Needs Category
Physiological Integrity – Pharmacological and Parenteral
Therapies
NCJMM Clinical Judgment Skill
Recognize Cues
Question 2
Clinical Scenario
A patient asks the nurse why the healthcare provider prescribed
a generic medication instead of the brand-name product.
Question
Which response by the nurse is most appropriate?
Options
, A. "Generic medications contain different active ingredients but
work similarly."
B. "Generic medications are required to demonstrate
bioequivalence to the brand-name medication."
C. "Generic medications are less effective because they cost
less."
D. "Generic medications have fewer adverse effects than brand-
name medications."
Correct Answer
B. Generic medications are required to demonstrate
bioequivalence to the brand-name medication.
Rationale
Approved generic medications contain the same active
ingredient, strength, dosage form, and route of administration
as the reference product and must demonstrate
bioequivalence, meaning they deliver comparable amounts of
drug into the bloodstream.
Why the Other Options Are Incorrect
A. Generic medications use the same active ingredient.
C. Lower cost reflects reduced development and marketing
expenses, not reduced effectiveness.
D. Generic and brand-name medications have comparable
safety profiles.
Pharmacology
9th Edition
Author(s)Rebecca G. Tucker
TEST BANK
Question 1
Clinical Scenario
A nurse is participating in a research seminar about the
development of a new antihypertensive medication. The
presenter explains that the drug has shown promising results in
laboratory studies and animal testing and is now being
prepared for testing in healthy human volunteers.
,Question
Which stage of drug development is the medication entering?
Options
A. Preclinical testing
B. Phase I clinical trial
C. Phase III clinical trial
D. Phase IV surveillance
Correct Answer
B. Phase I clinical trial
Rationale
Phase I clinical trials are the first studies involving human
participants, typically healthy volunteers. These trials focus
primarily on determining safety, dosage ranges,
pharmacokinetics, and identifying common adverse effects.
Why the Other Options Are Incorrect
A. Preclinical testing occurs before any human subjects are
enrolled and involves laboratory and animal studies.
C. Phase III trials involve large groups of patients with the target
condition to evaluate effectiveness and monitor adverse
reactions.
D. Phase IV surveillance occurs only after the medication
receives regulatory approval and is marketed.
,Learning Objective
Differentiate the phases of drug development and identify the
purpose of each phase.
Bloom's Taxonomy
Apply
Difficulty
Easy
NCLEX Client Needs Category
Physiological Integrity – Pharmacological and Parenteral
Therapies
NCJMM Clinical Judgment Skill
Recognize Cues
Question 2
Clinical Scenario
A patient asks the nurse why the healthcare provider prescribed
a generic medication instead of the brand-name product.
Question
Which response by the nurse is most appropriate?
Options
, A. "Generic medications contain different active ingredients but
work similarly."
B. "Generic medications are required to demonstrate
bioequivalence to the brand-name medication."
C. "Generic medications are less effective because they cost
less."
D. "Generic medications have fewer adverse effects than brand-
name medications."
Correct Answer
B. Generic medications are required to demonstrate
bioequivalence to the brand-name medication.
Rationale
Approved generic medications contain the same active
ingredient, strength, dosage form, and route of administration
as the reference product and must demonstrate
bioequivalence, meaning they deliver comparable amounts of
drug into the bloodstream.
Why the Other Options Are Incorrect
A. Generic medications use the same active ingredient.
C. Lower cost reflects reduced development and marketing
expenses, not reduced effectiveness.
D. Generic and brand-name medications have comparable
safety profiles.
